Oliver Mutschlechner

Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors

Beate Hintersteiner, Nico Lingg, Peiqing Zhang et al. · mAbs · 2016 · 101 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Microheterogeneity of therapeutic monoclonal antibodies is governed by changes in the surface charge of the protein

Beate Hintersteiner, Nico Lingg, Evelyne Janzek et al. · Biotechnology Journal · 2016 · 55 citations · Full text

Pharmacy, Biochemistry, Immunology +15

Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2

Sascha Troschke‐Meurer, Nikolai Siebert, Madlen Marx et al. · OncoImmunology · 2019 · 20 citations · Full text

Life Sciences, Immunology, Oncology +17

Adoptive cellular immunotherapy with APN401, autologous cbl-b silenced peripheral blood mononuclear cells: Data from a phase I study in patients with solid tumors.

Hans Loibner, Guenther Lametschwandtner, Kerstin Westritschnig et al. · Journal of Clinical Oncology · 2018 · 12 citations

Medicine, Immunology, Oncology +17

Immune Response and Outcome of High-Risk Neuroblastoma Patients Immunized with Anti-Idiotypic Antibody Ganglidiomab: Results from Compassionate-Use Treatments

Leah Klingel, Nikolai Siebert, Sascha Troschke‐Meurer et al. · Cancers · 2022 · 10 citations · Full text

Pharmacy, Immunology, Oncology +17